Evidence map›Paper›PMID 37143227›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2023

The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination.

C Geric, Z Z Qin, C M Denkinger, S V Kik, B Marais, A Anjos, P-M David, F Ahmad Khan, A Trajman

Open access · hybridAbstract read
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Evaluation of C-Reactive Protein and Computer-Aided Analysis of Chest X-rays as Tuberculosis Triage Tests at Health Facilities in Lesotho and South Africa.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Trial
  3. Current laboratory diagnostics for tuberculosis: from conventional approaches to next-generation molecular and immunological technologies.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  4. Evaluating the Cepheid Xpert TB/LTBI Research-Use-Only Assay for Detection of Active and Latent Mycobacterium tuberculosis Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  5. Closing gaps through innovation in the tuberculosis pathology value chain.Journal of clinical tuberculosis and other mycobacterial diseases · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Tuberculosis: An Ongoing Global Threat.Advances in experimental medicine and biology · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 5 countries.

C GericDivision of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC, Canada, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Montreal, QC, Canada, McGill International TB Centre, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Z Z QinStop TB Partnership, Geneva, Switzerland, Division of Infectious Diseases and Tropical Medicine, Heidelberg University Hospital, Heidelberg, Germany.
C M DenkingerDivision of Infectious Diseases and Tropical Medicine, Heidelberg University Hospital, Heidelberg, Germany, German Centre for Infection Research (DZIF), partner site of Heidelberg University Hospital, Heidelberg, Germany.
S V KikFIND, the Global Alliance for Diagnostics, Geneva, Switzerland.
B MaraisSydney Medical School and Sydney Infectious Diseases Institute, The University of Sydney, Westmead, NSW, Australia.
A AnjosIdiap Research Institute, Martigny, Switzerland.
P-M DavidFaculty of Pharmacy, Université de Montréal, Montréal, QC, Canada.
F Ahmad KhanDivision of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC, Canada, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Montreal, QC, Canada, McGill International TB Centre, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
A TrajmanMcGill International TB Centre, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, Departamento de Clínica Médica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Heidelberg University · DEMcGill University Health Centre · CAFIND · CHIdiap Research Institute · CHThe University of Sydney · AUUniversidade Federal do Rio de Janeiro · BRUniversité de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We provide an overview of the latest evidence on computer-aided detection (CAD) software for automated interpretation of chest radiographs (CXRs) for TB detection. CAD is a useful tool that can assist in rapid and consistent CXR interpretation for TB. CAD can achieve high sensitivity TB detection among people seeking care with symptoms of TB and in population-based screening, has accuracy on-par with human readers. However, implementation challenges remain. Due to diagnostic heterogeneity between settings and sub-populations, users need to select threshold scores rather than use pre-specified ones, but some sites may lack the resources and data to do so. Efficient standardisation is further complicated by frequent updates and new CAD versions, which also challenges implementation and comparison. CAD has not been validated for TB diagnosis in children and its accuracy for identifying non-TB abnormalities remains to be evaluated. A number of economic and political issues also remain to be addressed through regulation for CAD to avoid furthering health inequities. Although CAD-based CXR analysis has proven remarkably accurate for TB detection in adults, the above issues need to be addressed to ensure that the technology meets the needs of high-burden settings and vulnerable sub-populations.

Indexed as

Artificial IntelligenceTuberculosisAdultChildHumansRadiographyReadingSensitivity and SpecificityX-Rays

Identifiers

PMID37143227
PMCPMC10171486
OpenAlexW4372325002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.